Price
No data yet.
Social Signal Score
Revenue
$820.18B+76.42%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Koshiro Kudo
- Sector
- Industrials
- Industry
- Conglomerates
- Employees
- 47,895
- Beta
- 0.66
- Country
- JP
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.19
Financials
Revenue
$820.18B+76.4%Net Income
$53.38B+85.2%EBITDA
$132.90B+97.5%Free Cash Flow
$-41.13B-225.3%EPS (diluted)
$38.75+87.8%Shares Outstanding (diluted)
1.35B-3.1%Operating Expenses
$207.54BCash & Debt
$384.55BReturn of Capital
$47.43BDividend per Share
$0.14Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $3.09T | $159.79B | $118.24 |
| 2025 | $3.04T | $135.00B | $97.94 |
| 2024 | $2.78T | $43.81B | $31.60 |
| 2023 | $2.73T | $-91.31B | $-65.84 |
| 2022 | $2.46T | $161.88B | $116.68 |
| 2021 | $2.11T | $79.77B | $57.49 |
| 2020 | $2.15T | $103.93B | $74.85 |
| 2019 | $2.17T | $147.51B | $105.66 |
| 2018 | $2.04T | $170.25B | $121.93 |
| 2017 | $1.88T | $115.00B | $82.34 |
| 2016 | $1.94T | $91.75B | $65.69 |
| 2015 | $1.99T | $105.65B | $75.62 |
| 2014 | $1.90T | $101.30B | $72.48 |
| 2013 | $1.67T | $53.71B | $38.43 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from AHKSF's reported EPS growth of 9.0% a year over 13 years.
- EPS in 5 years
- $181.11
- Implied price
- $2,536
- Return from $10.30
- 200.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $1,261 — today's price is already 99.2% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 10 | 12 | 14 | 16 | 18 |
|---|---|---|---|---|---|
| -1.0% | 155.4% | 164.9% | 173.2% | 180.6% | 187.3% |
| 4.0% | 168.3% | 178.3% | 187.0% | 194.7% | 201.8% |
| 9.0% | 181.2% | 191.6% | 200.8% | 208.9% | 216.3% |
| 14.0% | 194.1% | 205.0% | 214.6% | 223.1% | 230.8% |
| 19.0% | 207.0% | 218.4% | 228.4% | 237.3% | 245.3% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
135+170.00%Social Signal Score
Mentions (3)
- Newsreuters.com·5h ago·Negative
US FDA approves Asahi Kasei's drug for persistent herpes infections The US FDA on Friday approved Japan's Asahi Kasei's drug for persistent herpes simplex virus sores in certain patients with weakened immune systems who have not responded to available antiviral treatments.
View source ↗ - Newsbusinesswire.com·11h ago·Neutral
Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall Elements TOKYO--(BUSINESS WIRE)--Asahi Kasei Microdevices held a ceremony to celebrate the recognition of the 1983 commercialization of thin-film Hall elements as an IEEE Milestone.
View source ↗ - Newsbusinesswire.com·51d ago·Neutral
Asahi Kasei's Capacity Expansion for Water Electrolysis and Chlor‑Alkali Equipment in Kawasaki Awarded Regional Economic Incentives TOKYO--(BUSINESS WIRE)--Asahi Kasei's project to build new facilities for electrolysis equipment has been awarded key regional economic incentives.
View source ↗
Earnings
Wed, Nov 11(in 5 weeks)
Consensus estimate $0.20 per share
Typical surprise +18.1% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Jul 31$0.24 vs $0.19beat
- Tue, May 12$0.18 vs $0.13beat
- Wed, Feb 4$0.26 vs $0.22beat
- Wed, Nov 5$0.23 vs $0.23beat
- Tue, Jul 29$0.10 vs $0.14miss
- Fri, May 9$0.18 vs $0.11beat
Estimates and results for AHKSF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
No disclosed congressional trades in AHKSF.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.